StockNews.com initiated coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a research note released on Thursday. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Price Performance Shares of NASDAQ VBLT opened at $0.22 on Thursday. The firm’s 50-day simple moving average is $0.26 and its 200 day […]
Vascular Biogenics (NASDAQ:VBLT) Now Covered by Analysts at StockNews com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Vascular Biogenics (NASDAQ:VBLT) Receives New Coverage from Analysts at StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com started coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a research report released on Wednesday. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Price Performance Shares of Vascular Biogenics stock remained flat at $0.25 on Wednesday. The company’s stock had a trading volume of 318,244 shares, […]
StockNews.com assumed coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Free Report) in a research note issued to investors on Wednesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Vascular Biogenics Stock Performance Shares of NASDAQ:VBLT remained flat at $0.25 during midday trading on Wednesday. The company had a trading volume […]